Novel Anti-IgG Drug Hits Mark in Sjogren's Patients

Watchdoq November 19, 2024
(MedPage Today) -- WASHINGTON -- A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a researcher reported here.
Patients receiving the infusion drug, called nipocalimab...

Read Full Article